Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2002

01-04-2002 | Conference Report

Hysteroscopic Assessment of Menopausal Breast-Cancer Patients Taking Tamoxifen; There is a Bias from the Mode of Endometrial Sampling in Estimating Endometrial Morbidity?

Authors: Giancarlo Garuti, Francesco Grossi, Fulvia Cellani, Giovanna Centinaio, Monica Colonnelli, Massimo Luerti

Published in: Breast Cancer Research and Treatment | Issue 3/2002

Login to get access
Metadata
Title
Hysteroscopic Assessment of Menopausal Breast-Cancer Patients Taking Tamoxifen; There is a Bias from the Mode of Endometrial Sampling in Estimating Endometrial Morbidity?
Authors
Giancarlo Garuti
Francesco Grossi
Fulvia Cellani
Giovanna Centinaio
Monica Colonnelli
Massimo Luerti
Publication date
01-04-2002
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1014957524845

Other articles of this Issue 3/2002

Breast Cancer Research and Treatment 3/2002 Go to the issue

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine